Faculty Disclosures
| Adrian A. Jarquin-Valdivia, MD, None |
No disclosure on file
|
| Sarice Bassin, MD |
No disclosure on file
|
| Yousef Mohammad, MD |
No disclosure on file
|
|
No disclosure on file
|
| Stephan A. Mayer, MD |
Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Phagenesis. Dr. Mayer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Astra Zeneca. Dr. Mayer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. Dr. Mayer has stock in Neuroptics. Dr. Mayer has received publishing royalties from a publication relating to health care. |
| Luis Fernandez |
No disclosure on file
|
| Gregory Christoforidis |
No disclosure on file
|
| Hamza I. Maqsood, MD |
Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca. |
| Andres Fernandez, MD |
No disclosure on file
|
| Augusto Parra, MD, MPH |
Dr. Parra has nothing to disclose. |
| Neeraj Badjatia, MD |
The institution of Dr. Badjatia has received research support from NIH/DOD. |
| Thomas P. Bleck, MD, FAAN |
Dr. Bleck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Bleck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Marinus Pharmaceuticals. Dr. Bleck has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for iECURE. Dr. Bleck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acasti. Dr. Bleck has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Society of Critical Care Medicine. Dr. Bleck has received research support from NIH. |
| David Darby, MBBS, PhD, FRACP |
No disclosure on file
|
| Andrew M. Naidech, MD, FAAN |
The institution of Dr. Naidech has received research support from NIH. Dr. Naidech has received publishing royalties from a publication relating to health care. |
| Paul R. McCrory, MD, MBBS, PhD |
No disclosure on file
|
| PHILLIP L. PEARL, MD, FAAN |
Dr. Pearl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Pearl has received publishing royalties from a publication relating to health care. Dr. Pearl has received publishing royalties from a publication relating to health care. Dr. Pearl has received publishing royalties from a publication relating to health care. Dr. Pearl has received publishing royalties from a publication relating to health care. |
| Kan Ding, MD |
The institution of Dr. Ding has received research support from National Institute of Aging. The institution of Dr. Ding has received research support from NINDS. |
| Caryn Harper |
No disclosure on file
|
| Ramon R. Diaz-Arrastia, MD, PhD, FAAN |
Dr. Diaz-Arrastia has stock in BrainBox, LLC. Dr. Diaz-Arrastia has stock in Nia Therpeutics. The institution of Dr. Diaz-Arrastia has received research support from National Institutes of Health. The institution of Dr. Diaz-Arrastia has received research support from Department of Defense. |
| Carol Moore |
No disclosure on file
|
| Michael D. Devous, Sr., PhD |
No disclosure on file
|
| Richard M. Dubinsky, MD, MPH, FAAN |
Dr. Dubinsky has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan Pharmaceuticals. An immediate family member of Dr. Dubinsky has stock in Abbvie and Abbott Labs. The institution of Dr. Dubinsky has received research support from CHDI. The institution of Dr. Dubinsky has received research support from Neurocrine. The institution of Dr. Dubinsky has received research support from Prilenia. The institution of Dr. Dubinsky has received research support from Sage Pharmaceuticals. |
| Sue M. Lai, PhD |
No disclosure on file
|
| Malik Adil, MBBS |
No disclosure on file
|
| Christine A. De Meulemeester, MD |
No disclosure on file
|
| Evan C. Lewis, MD |
No disclosure on file
|